Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,155.18
(
-1.14%
)
News Focus
News Focus
Post# of 2446
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: foolishpremise post# 378

Tuesday, 09/12/2006 3:52:25 PM

Tuesday, September 12, 2006 3:52:25 PM

Post# of 2446
>The market seems to like the [I-vation] news (up 5%).<

Indeed they do, and this is not unreasonable given that safety was the primary goal of the STRIDE trial.

But I have to assume that SRDX had hoped for a somewhat stronger showing of efficacy. The data are consistent with some of the InnoRx selling that we’ve talked about at length on this board. JMHO, FWIW

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SRDX News
More SRDX News